clinical trials
Zika Vaccine Ready for Human Trials
Zika Vaccine Ready for Human Trials
Catherine Offord | Jun 21, 2016
The US Food and Drug Administration has approved a clinical trial to test the vaccine on healthy adults.
Toward Targeted Therapies for Autoimmune Disorders
Toward Targeted Therapies for Autoimmune Disorders
Lawrence Steinman | Jun 1, 2016
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.
Journal to Publish Clinical Trial Protocols
Journal to Publish Clinical Trial Protocols
Tanya Lewis | May 18, 2016
Following an independent group’s finding of misreported outcomes, the Annals of Internal Medicine now requires that authors include clinical trial protocols when submitting their results.
Another Fatal-Disease Drug in Limbo
Another Fatal-Disease Drug in Limbo
Jef Akst | Apr 26, 2016
A federal advisory panel votes against Sarepta Therapeutics’s treatment for Duchenne muscular dystrophy.
Two NIH Labs Cease Reagent Production
Two NIH Labs Cease Reagent Production
Kerry Grens | Apr 20, 2016
Contamination concerns at cell therapy and radioactive tracer facilities spur production shutdowns.
Book Review: <em>Personal Trials</em>
Book Review: Personal Trials
Arthur L. Caplan | Mar 22, 2016
At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.
Cannabis-Based Drug for Epilepsy
Cannabis-Based Drug for Epilepsy
Jef Akst | Mar 14, 2016
A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 
More Support for Allergen-Exposure Strategy
More Support for Allergen-Exposure Strategy
Jef Akst | Mar 8, 2016
A second study finds evidence that feeding children peanuts could help prevent them from developing allergies to the legume later in life.
Desperately Seeking Shut-Eye
Desperately Seeking Shut-Eye
Anna Azvolinsky | Mar 1, 2016
New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.
Cautious Optimism About ZMapp Trial
Cautious Optimism About ZMapp Trial
Bob Grant | Feb 25, 2016
The Ebola drug increased survival in a small study, but the effect was not statistically significant.